Geron’s Imetelstat Faces Full Gamut Of US FDA Questions At ODAC Meeting

 
• By Derrick Gingery
  
blood transfusion
The imetelstat advisory committee documents included separate briefings from the FDA and Geron, rather than a combined package. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers